Cogent Biosciences, Inc. (COGT)
Nasdaq: COGT · CIK 0001622229 · United States
Every official Cogent Biosciences, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open COGT filings
Cogent Biosciences, Inc. documents
- Cogent Biosciences, Inc. 10-K 2026COGT 10-K 2026: annual report for fiscal 2026
- Cogent Biosciences, Inc. 10-K 2025COGT 10-K 2025: annual report for fiscal 2025
- Cogent Biosciences, Inc. 10-K 2024COGT 10-K 2024: annual report for fiscal 2024
- Cogent Biosciences, Inc. 10-K 2023COGT 10-K 2023: annual report for fiscal 2023
- Cogent Biosciences, Inc. 10-K 2022COGT 10-K 2022: annual report for fiscal 2022
- Cogent Biosciences, Inc. 10-Q 2026COGT 10-Q 2026: quarterly report for fiscal 2026
- Cogent Biosciences, Inc. 10-Q 2025COGT 10-Q 2025: quarterly report for fiscal 2025
- Cogent Biosciences, Inc. 10-Q 2024COGT 10-Q 2024: quarterly report for fiscal 2024
- Cogent Biosciences, Inc. 10-Q 2023COGT 10-Q 2023: quarterly report for fiscal 2023
- Cogent Biosciences, Inc. 10-Q 2022COGT 10-Q 2022: quarterly report for fiscal 2022
- Cogent Biosciences, Inc. 8-K 2026COGT 8-K 2026: current report for fiscal 2026
- Cogent Biosciences, Inc. 8-K 2025COGT 8-K 2025: current report for fiscal 2025
- Cogent Biosciences, Inc. 8-K 2024COGT 8-K 2024: current report for fiscal 2024
- Cogent Biosciences, Inc. 8-K 2023COGT 8-K 2023: current report for fiscal 2023
- Cogent Biosciences, Inc. 8-K 2022COGT 8-K 2022: current report for fiscal 2022
- Cogent Biosciences, Inc. DEF 14A 2026COGT DEF 14A 2026: proxy statement for fiscal 2026
- Cogent Biosciences, Inc. DEF 14A 2025COGT DEF 14A 2025: proxy statement for fiscal 2025
- Cogent Biosciences, Inc. DEF 14A 2024COGT DEF 14A 2024: proxy statement for fiscal 2024
- Cogent Biosciences, Inc. DEF 14A 2023COGT DEF 14A 2023: proxy statement for fiscal 2023
- Cogent Biosciences, Inc. DEF 14A 2022COGT DEF 14A 2022: proxy statement for fiscal 2022
- Cogent Biosciences, Inc. Form 4 2026COGT Form 4 2026: insider trading filing for fiscal 2026
- Cogent Biosciences, Inc. Form 4 2025COGT Form 4 2025: insider trading filing for fiscal 2025
- Cogent Biosciences, Inc. Form 4 2024COGT Form 4 2024: insider trading filing for fiscal 2024
- Cogent Biosciences, Inc. Form 4 2023COGT Form 4 2023: insider trading filing for fiscal 2023
- Cogent Biosciences, Inc. Form 4 2022COGT Form 4 2022: insider trading filing for fiscal 2022
- Cogent Biosciences, Inc. S-1 2026COGT S-1 2026: registration statement for fiscal 2026
- Cogent Biosciences, Inc. S-1 2025COGT S-1 2025: registration statement for fiscal 2025
- Cogent Biosciences, Inc. S-1 2024COGT S-1 2024: registration statement for fiscal 2024
- Cogent Biosciences, Inc. S-1 2023COGT S-1 2023: registration statement for fiscal 2023
- Cogent Biosciences, Inc. S-1 2022COGT S-1 2022: registration statement for fiscal 2022
- Cogent Biosciences, Inc. 13F 2026COGT 13F 2026: institutional holdings for fiscal 2026
- Cogent Biosciences, Inc. 13F 2025COGT 13F 2025: institutional holdings for fiscal 2025
- Cogent Biosciences, Inc. 13F 2024COGT 13F 2024: institutional holdings for fiscal 2024
- Cogent Biosciences, Inc. 13F 2023COGT 13F 2023: institutional holdings for fiscal 2023
- Cogent Biosciences, Inc. 13F 2022COGT 13F 2022: institutional holdings for fiscal 2022
More companies